Latest / Views and News with Clarence Ford / SA’s medical supply shortage
Transcript
- 0:00Speaker 1: Richard Slaven, Portfolio Manager at Anstam Medical, joins us on
- 0:04Speaker 1: the line again today. I hope the gremlins are not
- 0:06Speaker 1: going to spoil this conversation this time around, Richard.
- 0:09Speaker 2: Good morning, Clarence. Good morning, listeners. Hopefully you can hear
- 0:12Speaker 2: me today.
- 0:12Speaker 1: Yeah, I know. And I think we got a home
- 0:14Speaker 1: in on the important elements. What you said yesterday was
- 0:18Speaker 1: very critical medicinal shortages today. Are we talking morphine? Are
- 0:23Speaker 1: we talking oncology kind of treatments? Are we talking psychiatric
- 0:29Speaker 1: kind of treatments? And others are impacting state hospitals to
- 0:35Speaker 1: the extent that even theater surgery has been delayed, postponed.
- 0:43Speaker 1: Let's just summarize what you started off with yesterday.
- 0:47Speaker 2: Yeah, so I think if I can, I've got a
- 0:49Speaker 2: very good example that will... speak to a national problem,
- 0:53Speaker 2: and then we can even bring it into Cape Town itself.
- 0:57Speaker 2: So a very common condition that is going to affect
- 1:00Speaker 2: most of us at some stage of our life is osteoarthritis.
- 1:04Speaker 2: We've all heard of osteoarthritis. It is probably the most
- 1:07Speaker 2: common joint condition, and it's where your cartilage, which cushions
- 1:12Speaker 2: the ends of bones, gradually wears down over time. And
- 1:15Speaker 2: many of your listeners of a certain age, because it
- 1:17Speaker 2: normally sort of affects people from about the age of
- 1:19Speaker 2: 40 onwards, will recognize these sort of symptoms, pain when
- 1:23Speaker 2: they exercise or movement, and sometimes even after doing exercise
- 1:28Speaker 2: and movement. So it's sometimes normal to get pain after exercise,
- 1:34Speaker 2: but if that pain is still going on three or
- 1:36Speaker 2: four days later, that is not normal. Joint stiffness, reduced
- 1:40Speaker 2: flexibility and movement, a grating sensation. So if your knee
- 1:44Speaker 2: starts talking back to you when you're moving it, You're
- 1:48Speaker 2: aware of it. And eventually this sometimes leads to bone
- 1:51Speaker 2: spurs and deformities because you've got bone rubbing against bone.
- 1:55Speaker 2: So if we look at the South African population, 21.3
- 1:58Speaker 2: million people are over the age or roughly over the
- 2:01Speaker 2: age of 40. And if we look at the world statistics, 23%
- 2:06Speaker 2: of these patients will suffer with osteoarthritis. So from the
- 2:09Speaker 2: age of 40 upwards, 23%, more than one in five patients,
- 2:14Speaker 2: But it really does, because it's a degenerative disease and
- 2:18Speaker 2: it is linked with age as one of the factors,
- 2:21Speaker 2: from the age of 40 to 49, only 5% of patients,
- 2:25Speaker 2: so 1 in 20 patients will suffer with osteoarthritis. But
- 2:29Speaker 2: when you're now 60 to 69 and we all want
- 2:31Speaker 2: to live a long and fruitful life, the percentage totally changes.
- 2:37Speaker 2: It becomes converse and it's 20%. So 1 in 5 patients.
- 2:41Speaker 2: One in five patients over the age of 60 will
- 2:43Speaker 2: suffer with osteoarthritis. Now, if we look at this in
- 2:47Speaker 2: terms of their levels, and it affects all joints where you.
- 2:53Speaker 1: Have I think, Richard, we understand osteoarthritis, but to what
- 2:59Speaker 1: extent are HIV-positive patients impacted? And we have palliative care
- 3:08Speaker 1: that requires morphine. My research suggests that we have shortages
- 3:13Speaker 1: on that front as well. What about psychotic patients that
- 3:16Speaker 1: need treatment from their psychiatrist?
- 3:20Speaker 2: Yeah, so where I was going to bring it back
- 3:22Speaker 2: to surgery was, and this is the easiest way to
- 3:25Speaker 2: just to show an easy example is we do about
- 3:28Speaker 2: 8,000 to 10,000 total knee replacement surgeries a year in
- 3:31Speaker 2: South Africa. And, and if you look at the population
- 3:35Speaker 2: that would be walking around with symptomatic, um, so, so
- 3:40Speaker 2: grade three or worse osteoarthritis, we're looking at a population
- 3:43Speaker 2: of anywhere between two and 2.8 million people. So you
- 3:46Speaker 2: can just, that just highlights the shortage. So it's always
- 3:49Speaker 2: been something that we in South Africa have to live with. Um, Unfortunately,
- 3:54Speaker 2: there's a shortage of staff, nurses, doctors, devices. Now it's
- 4:00Speaker 2: becoming medication. These are just the practicalities that we have
- 4:06Speaker 2: to work with. And you mentioned the first question was,
- 4:09Speaker 2: is it a shortage because of India and China? I
- 4:12Speaker 2: think we have to look internally at ourselves first.
- 4:16Speaker 1: I think you mentioned that because I asked you if
- 4:18Speaker 1: the whole world was in this together and you said no.
- 4:21Speaker 1: You said it's procurement issues that we have at state hospitals.
- 4:25Speaker 2: Well, I think the whole world is struggling a little
- 4:28Speaker 2: bit because of what's happening in the Middle East. I
- 4:31Speaker 2: think petrol prices affect everyone, price inflation, people can't get
- 4:36Speaker 2: access to everything that they needed. But a lot of
- 4:39Speaker 2: this has started before. It's too simplistic to blame it
- 4:43Speaker 2: on what's happening in the Middle East because these sort
- 4:45Speaker 2: of things were happening already in 2021. Tigerberg did a
- 4:51Speaker 2: did a study on total knee replacement surgery. And the
- 4:54Speaker 2: average patient waited 3.9 years for that surgery.
- 4:59Speaker 1: You haven't expressed yourself on the other conditions that may
- 5:02Speaker 1: be impacted that I mentioned. Is that just outside of
- 5:06Speaker 1: your purview? You don't have a view on that? Because
- 5:09Speaker 1: my research suggests that there are shortages there as well.
- 5:13Speaker 2: Sorry. Yeah, the reason why I keep bringing it back
- 5:17Speaker 2: to surgery is because we are a medical device company.
- 5:19Speaker 1: Okay, right. So you can talk about the products that
- 5:21Speaker 1: you have direct sight of.
- 5:23Speaker 2: Well, I can talk about the backlog of surgery. I
- 5:25Speaker 2: don't think it's– I don't have enough information on pharmaceuticals.
- 5:30Speaker 1: I get worried.
- 5:31Speaker 2: What I can say to you, though, is that last
- 5:35Speaker 2: night my wife and I were talking, and she said
- 5:38Speaker 2: to me, what do you think is the number one
- 5:40Speaker 2: pharmaceutical company in terms of growth in the world? I said,
- 5:43Speaker 2: I'm sure it's Eli Lilly because of their weight loss
- 5:47Speaker 2: and diabetic products. She said, you're right. The third company
- 5:51Speaker 2: was Amgen. Both of those companies are no longer directly
- 5:56Speaker 2: involved in South Africa.
- 5:57Speaker 1: Okay, so there are multiple issues. You did say that
- 6:01Speaker 1: this primarily affects the public sector. You said that yesterday.
- 6:05Speaker 1: Of course, the workers in the public sector and the
- 6:10Speaker 1: politicians have medical aid. They got gems. So they would
- 6:13Speaker 1: use the private sector and not be subject to the inconvenience,
- 6:20Speaker 1: not to mention the pain that the people of South
- 6:22Speaker 1: Africa will suffer.
- 6:24Speaker 2: Yeah, absolutely. And so we've got to try and find
- 6:27Speaker 2: ways to try and reduce the pain while patients are
- 6:31Speaker 2: waiting for these life-altering treatments. That's the question. And what's happening,
- 6:39Speaker 2: and what I was trying to paint a picture for you,
- 6:40Speaker 2: was that a lot of the multinationals have withdrawn from
- 6:44Speaker 2: South Africa. And it was, I think I mentioned yesterday,
- 6:47Speaker 2: that I was involved with a German company. I co-promoted
- 6:52Speaker 2: at one stage with an American multinational company. A British
- 6:56Speaker 2: multinational pulled out quite a while. So it's not just
- 7:02Speaker 2: the U.S. It is the U.S. and Europe. Africa is
- 7:06Speaker 2: becoming difficult. They are rather saying, okay, we'll give it
- 7:09Speaker 2: to South African distributors. You guys deal with staffing, with
- 7:15Speaker 2: resource allocation, with purchasing, and we will just take our royalties. Now,
- 7:20Speaker 2: what becomes difficult for, especially if you're a small South
- 7:24Speaker 2: African distributor, is you have to, in South Africa, you
- 7:28Speaker 2: have to be able to do business in the private
- 7:31Speaker 2: sector and get paid by the hospital groups every 28
- 7:35Speaker 2: days to survive. And only if you are strong in
- 7:39Speaker 2: the private sector can you take a chance on the
- 7:41Speaker 2: state sector. Because all the businesses that operated primarily targeting
- 7:48Speaker 2: the state sector Those companies don't exist anymore because they
- 7:51Speaker 2: didn't get paid in time. Nobody can wait two or
- 7:55Speaker 2: three years for payment. When you've got to pay for
- 7:58Speaker 2: most of these products are produced overseas, you've got to
- 8:00Speaker 2: pay for your staff, you've got to pay for product,
- 8:02Speaker 2: you've got to pay for warehousing, logistics. And then so
- 8:06Speaker 2: that became a major issue. We used to be involved
- 8:09Speaker 2: with the state in 2017. In 2021, we stopped doing
- 8:16Speaker 2: state business.
- 8:17Speaker 1: I think we got the issues there. Richard Slavin, thank
- 8:20Speaker 1: you for bringing it to our attention. I think it's
- 8:22Speaker 1: important that we pursue this further and understand the extent
- 8:27Speaker 1: to which South Africans are impacted. I really am worried
- 8:32Speaker 1: about what my research indicated yesterday. And, of course, Richard
- 8:37Speaker 1: Slavin says some of that information products fall outside of
- 8:41Speaker 1: his purview, and he doesn't want to necessarily stick his
- 8:43Speaker 1: neck out on those, but he's talking to what he
- 8:47Speaker 1: has direct sight of, and I understand that. It looks
- 8:50Speaker 1: as if there are challenges on that particular front.